High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Occidental (OXY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Pharmaceutical company AbbVie (NYSE:ABBV) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.2% year on year to $16.99 billion. Its non-GAAP profit of $3.65 per share was 1.2% above analysts’ consensus estimates.
American and South Korean semiconductor and storage companies recovered a bit from an earlier selloff after fresh positive signs from Big Tech earnings.
AbbVie (ABBV) delivered earnings and revenue surprises of +0.28% and +1.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Many space ETFs offer diversified exposure to the space economy.
AWS backlog reached $496 billion as capacity still trails demand
Dominion Energy (D) delivered earnings and revenue surprises of +8.22% and +10.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Amazon Stock Soars as AWS Growth Accelerates and Profits Smash Forecasts
SANM, U and NVDA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 31, 2026.
The electrical infrastructure supplier reported second-quarter earnings per share of $3.15, with sales of $8.5 billion. Wall Street was looking for EPS of $3.07 and sales of $8.2 billion.
In its first year, BCC Research's Artificial Intelligence vertical has developed a comprehensive suite of reports to provide a detailed view of the global AI market. This collection includes quarterly Core Four reports alongside monthly Pulse Reports and an AI Sentiment Index, offering insights into AI adoption, disruption, usage, and investment across various industries worldwide. Notably, the reports highlight a structural shift in industries such as finance, logistics, and digital health,...
AbbVie lowered its full-year adjusted earnings outlook to account for its acquisition of Apogee Therapeutics, as the company logged higher profit and revenue in the recent quarter.
The IPO market has made an impressive comeback this year. Momentum began building in the first quarter and accelerated in the second, with traditional IPOs raising $114.1 billion through June 30, 2026 – roughly seven times the amount raised during the first half of 2025. SpaceX, the largest IPO in Wall Street history, understandably dominated the headlines and made Elon Musk the world’s first trillionaire, but the strength of the market extended well beyond a single blockbuster listing.Claim 55%
Arm delivered solid results, but all eyes are on its upcoming AGI CPU chip.
AbbVie shares took a hit Friday after costs related to the drugmaker’s acquisition of Apogee Therapeutics forced a cut to its full-year profit outlook. Second-quarter revenue jumped 10% to nearly $17 billion, beating the $16.8 billion consensus estimate among analysts polled by FactSet. AbbVie posted adjusted earnings of $3.65 a share, narrowly ahead of Wall Street’s call for $3.60.
CHKP tops Q2 earnings estimates as subscription revenues rise and AI security demand expands, even as product sales and cash flow face pressure.
Robinhood Markets (Nasdaq: HOOD) reported its earnings for the second quarter of 2026 on July 29. The brokerage platform, popular for its equity, crypto, and tokenized stock offerings, generated $1.31 billion in revenue and $0.62 in earnings per share (EPS), beating Wall ...
Chevron’s global production rose 20% as its reportedly limited exposure to the Middle East helped it benefit from higher oil prices with fewer supply disruptions.
The nearly 20-year-old product line was quite the hot seller during the period.
The e-commerce and cloud giant topped second quarter expectations as accelerating cloud growth at Amazon Web Services (AWS) helped drive strong results.
The e-commerce and cloud giant topped second quarter expectations as accelerating cloud growth at Amazon Web Services (AWS) helped drive strong results.
As AI stocks dominate headlines, Coca-Cola reminds investors that quality businesses continue creating long-term wealth.
Moderna (MRNA) delivered earnings and revenue surprises of 0.00% and +14.49%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Cactus posts strong growth in Q2 2026 as international Pressure Control and Spoolable Technologies demand lifts earnings and backlog.
AI-driven power demand puts Bloom Energy's commercial scale against OKLO's advanced nuclear ambitions in a high-stakes clean energy comparison.
Stock Market Today: The Dow Jones index rises Friday even as Apple dives on a weak sales forecast. Amazon stock surges on earnings.
MPWR topped Q2 estimates as Enterprise Data revenue surged 164.3% and margins widened. Q3 sales are projected to be $1.14-$1.16 billion.
The ongoing race to become the blockchain of choice for institutional finance is increasingly shifting beyond stablecoins to tokenized Treasury products. The latest entrant is Stripe’s blockchain Tempo, which has integrated BlackRock’s USD Institutional Digital Liquidity Fund (BUIDL) into its ecosystem. It gives eligible users access to the world’s largest tokenized money market fund and
Amazon.com (AMZN) shares were soaring early Friday after the e-commerce giant's second-quarter resul
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
